Related Experiment Video
Updated: Feb 10, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
[Effects of MSP on Cell Cycle and EMT of Non-Small Cell Lung Cancer PC14]
Xue-Ni Shi1, Shi-Hang Wei1, Xu Peng2
1College of Life Science, Sichuan University,Chengdu 610041,China.
Objective:
To study the effect of macrophage stimulating protein (MSP) on the cell cycle of non-small cell lung cancer PC14 cells without expression of recepteur d'originenanta (RON) and MSP,and analyse its effect on PC14's epithelial mesenchymal transition (EMT) capacity.
Methods:
Vitro culture PC14 (blank control),PC14-Mst1-pEGFP-N1 (stablely expressed MSP) and PC14-pEGFP-N1. Cell cycles were detected by flow cytometry and the gaps between cells during growth were measured by transmission electron microscope (TEM); RT-PCR and Western blot were used to figure out the shifts of EMT related gene expression in PC14-Mst1-pEGFP-N1 cells.
Results:
Compared with the PC14 group and PC14-pEGFP-N1 group,PC14-Mst1-pEGFP-N1 population of G1/G0 phase were significantly increased while S and G2/M phase were significantly reduced;The gaps between PC14-Mst1-pEGFP-N1 cells decreased; RT-PCR and Western blot showed that mRNA and protein levels of E-cadherin of PC14-Mst1-pEGFP-N1 were significantly higher than that of PC14,but mRNA and protein levels of Vimentin were significantly lower.
Conclusion:
MSP may affect the cell cycle of PC14 and inhibit its EMT procedure by regulating the expression of related proteins including E-cadherin and Vimentin when RON was not expressed.
Insights
Macrophage stimulating protein (MSP) halts non-small cell lung cancer cell cycle progression and inhibits epithelial-mesenchymal transition (EMT) in RON-negative PC14 cells. This suggests MSP as a potential therapeutic target for lung cancer.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
- Epithelial-mesenchymal transition (EMT) is a critical process in cancer progression and metastasis.
- The role of macrophage stimulating protein (MSP) in NSCLC, particularly in RON-negative cells, requires further elucidation.
Purpose of the Study:
- To investigate the impact of macrophage stimulating protein (MSP) on the cell cycle of non-small cell lung cancer (NSCLC) PC14 cells lacking RON expression.
- To analyze the effect of MSP on the epithelial-mesenchymal transition (EMT) capacity of these PC14 cells.
Main Methods:
- PC14 cells were cultured and engineered to stably express MSP (PC14-Mst1-pEGFP-N1) or a control vector (PC14-pEGFP-N1).
- Cell cycle distribution was analyzed using flow cytometry.
- Cellular morphology and intercellular gaps were examined via transmission electron microscopy (TEM).
- Gene and protein expression of EMT markers (E-cadherin, Vimentin) were assessed using RT-PCR and Western blot.
Main Results:
- MSP expression significantly increased the G1/G0 phase population while decreasing S and G2/M phases in PC14 cells.
- Intercellular gaps between PC14-Mst1-pEGFP-N1 cells were reduced compared to controls.
- RT-PCR and Western blot revealed significantly elevated E-cadherin and reduced Vimentin mRNA and protein levels in MSP-expressing cells.
Conclusions:
- Macrophage stimulating protein (MSP) influences the cell cycle of RON-negative PC14 cells, promoting G1/G0 arrest.
- MSP inhibits the epithelial-mesenchymal transition (EMT) in these cells by upregulating E-cadherin and downregulating Vimentin.
- These findings suggest MSP's potential as a therapeutic target for NSCLC, particularly in tumors lacking RON expression.
Related Concept Videos
What is the Cell Cycle?
What is the Cell Cycle?
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System
Mitogens and the Cell Cycle
DNA Damage Can Stall the Cell Cycle

